YungShin Global Holding Corporation (TPE:3705)
Taiwan · Delayed Price · Currency is TWD 58.60
+0.40 (0.69%)
Oct 23, 2025, 2:36 PM CST
YungShin Global Holding Market Cap
YungShin Global Holding has a market cap or net worth of 15.61 billion as of October 24, 2025. Its market cap has decreased by -4.87% in one year.
Market Cap
15.61B
Enterprise Value
14.85B
Revenue
8.56B
Ranking
n/a
PE Ratio
15.84
Stock Price
58.60
Market Cap Chart
Since January 4, 2011, YungShin Global Holding's market cap has increased from 10.25B to 15.61B, an increase of 52.30%. That is a compound annual growth rate of 2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 15.61B | 8.72% |
| Dec 31, 2024 | 14.36B | 15.91% |
| Dec 29, 2023 | 12.39B | 1.09% |
| Dec 30, 2022 | 12.25B | 7.10% |
| Dec 30, 2021 | 11.44B | -3.92% |
| Dec 31, 2020 | 11.91B | 4.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 255.14B |
| PharmaEssentia | 190.10B |
| Bora Pharmaceuticals Co., LTD. | 80.18B |
| Lotus Pharmaceutical | 76.53B |
| Lumosa Therapeutics | 52.22B |
| Oneness Biotech | 30.13B |
| Polaris Group | 27.66B |
| Center Laboratories | 25.79B |